K Kotseva

Summary

Affiliation: Imperial College
Country: UK

Publications

  1. doi request reprint EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries
    Kornelia Kotseva
    Department of Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, London, UK
    Eur J Cardiovasc Prev Rehabil 17:530-40. 2010
  2. doi request reprint ASPIRE-2-PREVENT: a survey of lifestyle, risk factor management and cardioprotective medication in patients with coronary heart disease and people at high risk of developing cardiovascular disease in the UK
    Kornelia Kotseva
    Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, St Mary s Campus, International Centre for Circulatory Health, Lower 3rd Floor, 59 61 North Wharf Road, London W2 1LA, UK
    Heart 98:865-71. 2012
  3. ncbi request reprint Global preventive policies. Strategies at European and worldwide level
    Kornelia Kotseva
    Cardiovascular Medicine, National Heart and Lung Institute, Imperial College, London, UK
    Rev Esp Cardiol 61:960-70. 2008
  4. ncbi request reprint Treatment potential for cholesterol management in patients with coronary heart disease in 15 European countries: findings from the EUROASPIRE II survey
    K Kotseva
    Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, Charing Cross Hospital 5th Floor, Laboratory Block, Fulham Palace Road, London W6 8RF, United Kingdom
    Atherosclerosis 197:710-7. 2008
  5. doi request reprint Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries
    Kornelia Kotseva
    Department of Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, London, UK
    Lancet 373:929-40. 2009
  6. doi request reprint EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries
    Kornelia Kotseva
    Department of Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, London, UK
    Eur J Cardiovasc Prev Rehabil 16:121-37. 2009
  7. doi request reprint Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlle
    D A Wood
    Department of Cardiovascular Medicine, National Heart and Lung Institute at Charing Cross Campus, Imperial College, London, UK
    Lancet 371:1999-2012. 2008
  8. ncbi request reprint [Cardiovascular risk reduction: impact of an international project]
    B Colle
    Direzione Sanitaria A S S n 3 Alto Friuli
    Ann Ig 20:43-8. 2008
  9. ncbi request reprint Screening of family members of patients with premature coronary heart disease; results from the EUROASPIRE II family survey
    J De Sutter
    Department of Public Health, University Hospital, De Pintelaan 185, 9000, Gent, Belgium
    Eur Heart J 24:249-57. 2003
  10. ncbi request reprint Cardiovascular effects in viscose rayon workers exposed to carbon disulfide
    K Kotseva
    Department of Public Health, Ghent University, Belgium
    Int J Occup Environ Health 7:7-13. 2001

Detail Information

Publications10

  1. doi request reprint EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries
    Kornelia Kotseva
    Department of Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, London, UK
    Eur J Cardiovasc Prev Rehabil 17:530-40. 2010
    ..To determine whether the 2003 Joint European Societies' guidelines on cardiovascular disease prevention in people at high cardiovascular risk have been followed in general practice...
  2. doi request reprint ASPIRE-2-PREVENT: a survey of lifestyle, risk factor management and cardioprotective medication in patients with coronary heart disease and people at high risk of developing cardiovascular disease in the UK
    Kornelia Kotseva
    Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, St Mary s Campus, International Centre for Circulatory Health, Lower 3rd Floor, 59 61 North Wharf Road, London W2 1LA, UK
    Heart 98:865-71. 2012
    ....
  3. ncbi request reprint Global preventive policies. Strategies at European and worldwide level
    Kornelia Kotseva
    Cardiovascular Medicine, National Heart and Lung Institute, Imperial College, London, UK
    Rev Esp Cardiol 61:960-70. 2008
    ..The guidelines provide guidance to policy-makers and health care workers on how to target high risk people in different resource settings, using evidence-based and cost-effective preventive approaches...
  4. ncbi request reprint Treatment potential for cholesterol management in patients with coronary heart disease in 15 European countries: findings from the EUROASPIRE II survey
    K Kotseva
    Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, Charing Cross Hospital 5th Floor, Laboratory Block, Fulham Palace Road, London W6 8RF, United Kingdom
    Atherosclerosis 197:710-7. 2008
    ..This has prompted international guidelines on prevention of CHD to include recommendations on dietary and pharmacological treatment of hyperlipidaemia with set goals on total- and LDL-cholesterol...
  5. doi request reprint Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries
    Kornelia Kotseva
    Department of Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, London, UK
    Lancet 373:929-40. 2009
    ....
  6. doi request reprint EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries
    Kornelia Kotseva
    Department of Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, London, UK
    Eur J Cardiovasc Prev Rehabil 16:121-37. 2009
    ....
  7. doi request reprint Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlle
    D A Wood
    Department of Cardiovascular Medicine, National Heart and Lung Institute at Charing Cross Campus, Imperial College, London, UK
    Lancet 371:1999-2012. 2008
    ..Our aim was to investigate whether a nurse-coordinated multidisciplinary, family-based preventive cardiology programme could improve standards of preventive care in routine clinical practice...
  8. ncbi request reprint [Cardiovascular risk reduction: impact of an international project]
    B Colle
    Direzione Sanitaria A S S n 3 Alto Friuli
    Ann Ig 20:43-8. 2008
    ..The experimented intervention model based on a multidisciplinary approach and nurses leaded showed a good one year impact in reducing cardiovascular risk factors in high risk people. This model should be further tested in local contexts...
  9. ncbi request reprint Screening of family members of patients with premature coronary heart disease; results from the EUROASPIRE II family survey
    J De Sutter
    Department of Public Health, University Hospital, De Pintelaan 185, 9000, Gent, Belgium
    Eur Heart J 24:249-57. 2003
    ....
  10. ncbi request reprint Cardiovascular effects in viscose rayon workers exposed to carbon disulfide
    K Kotseva
    Department of Public Health, Ghent University, Belgium
    Int J Occup Environ Health 7:7-13. 2001
    ..The findings suggest that the coronary risk is increased in workers previously exposed to high CS2 concentrations but not in those exposed to CS2 levels below the current TLV...